In addition, another study has shown how the transplantation of stool to germ-free mice could improve the efficacy of anti-PD-L1 immunotherapy in mice that received responder-stool by increasing the density of CD8+ T-cells and reducing FoxP3+ CD4+ Tregs in the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.